Home / Industrial research and experimental development project
Industrial research and experimental development project
Industrial research and experimental development project
AI-Driven technologies for scientific research
Almaviva Digitaltec, a digital foundry specializing in projects based on digital and disruptive technologies, and Almawave, a leader in artificial intelligence and natural language analysis, both companies of Almaviva Group, have signed with Regione Puglia a program contract, namely "OncologIA", for research activities and innovative IT technology experimentation within the medical-oncological field.
Project
OncologIA is an industrial research and experimental development project, co-funded by the Apulia Region through the European Regional Development Fund operational project Puglia ERDF 2014 - 2020, for the application of innovative IT technologies in the field of oncological medicine.
Objective
The OncologIA project enables a highly precise modus operandi through the “sustainable” use of artificial intelligence and data, in compliance with the regulations that govern these applications and their ethical implications, these too binding.
The field of oncology is one of the most advanced specialties to date, with a significant network of services in which the “precision” approach, or rather an approach that’s customized to the specific patient, ensures crucial differences in outcomes. Furthermore, it requires access to significant volumes of high quality data, as well as a high number of potential users.
The project lays the foundation for creating a reference framework, managed in the cloud, within which an ad-hoc eco-system allows for various levels of AI and ML technology use: from predictive algorithms and algorithms which provide decision-support in clinical and logistical settings, to the establishment of Digital Healthcare Identities (IDS). The latter represents an advanced and digital model of real patients, connected through specific sensors and devices and capable of providing doctors and/or caregivers with a near-real-time “view” of their patient’s condition.
A challenging test bed for trying out concepts and implementations that are technically and scientifically sound and are also easy to adopt by both professionals and the patients themselves.
Specifications and technological requirements that the project meets:
Cryptographic mechanisms and data validation
during the advanced collection and distribution phase (homomorphic IHE, PHE, and FHE encryption and strong anonymization)
High security Standards
also using differential privacy mechanisms for secure access to data (consent, revocation, and access logging, and with verification for IoT devices, wearables, etc., too)
Privacy compliance
through stringent adherence to national and international standards when it comes to the processing of personal data
Advanced Digital Twin
and a new management model for decentralized digital healthcare identities
Advanced “Health What If Analysis” system
for the analysis, visualization, and simulation of single and multiple models
Advanced analytics tools
based on artificial intelligence techniques for processing clinical data
Zero Knowledge Proof (ZKP) Techniques
to mathematically confirm the correctness of the association between the patient and the data that represents them within the system
Artificial Intelligence algorithms
to support the patient treatment and management model, through data-driven algorithms
Evolution of classic models of oncological treatment
through the dynamic management of assets corresponding to the identified macro-areas and interconnected to create a network of information in graph format, thus making it possible to analyze processes and rank the collected information
Use of frameworks related to the topic of ethical AI
to assess and manage (as required by European guidelines) the risks associated with the use of AI-based tools
Specifications and technological requirements that the project meets:
Cryptographic mechanisms and data validation
during the advanced collection and distribution phase (homomorphic IHE, PHE, and FHE encryption and strong anonymization)
High security Standards
also using differential privacy mechanisms for secure access to data (consent, revocation, and access logging, and with verification for IoT devices, wearables, etc., too)
Privacy compliance
through stringent adherence to national and international standards when it comes to the processing of personal data
Advanced Digital Twin
and a new management model for decentralized digital healthcare identities
Advanced “Health What If Analysis” system
for the analysis, visualization, and simulation of single and multiple models
Advanced analytics tools
based on artificial intelligence techniques for processing clinical data
Zero Knowledge Proof (ZKP) Techniques
to mathematically confirm the correctness of the association between the patient and the data that represents them within the system
Artificial Intelligence algorithms
to support the patient treatment and management model, through data-driven algorithms
Evolution of classic models of oncological treatment
through the dynamic management of assets corresponding to the identified macro-areas and interconnected to create a network of information in graph format, thus making it possible to analyze processes and rank the collected information
Use of frameworks related to the topic of ethical AI
to assess and manage (as required by European guidelines) the risks associated with the use of AI-based tools
Project summary:
Name of beneficiaries
Almaviva Digitaltec s.r.l.
proponent
Almawave S.p.A.
adherent
Project summary:
Name of beneficiaries
Almaviva Digitaltec s.r.l.
proponent
Almawave S.p.A.
adherent
Operation name
OncologIA
Operation start date
07/02/2022
Operation end date
31/12/2023
(subject to extensions)
Total eligible expenditure allocated to the operation
Almaviva Digitaltec S.r.l.
Eligible investment: €4.440.713,92
Eligible grant assistance: €2.458.557,85
Almawave S.p.A.
Eligible investment: €1.900.668,55
Eligible grant assistance: €1.071.875,23
Total eligible expenditure allocated to the operation
Almaviva Digitaltec S.r.l.
Eligible investment: €4.440.713,92
Eligible grant assistance: €2.458.557,85
Almawave S.p.A.
Eligible investment: €1.900.668,55
Eligible grant assistance: €1.071.875,23
EU co-financing rate (by priority axis)
Industrial research 65%
Experimental development 40%
Operation post code
Almaviva Digitaltec S.r.l.
70010 Valenzano (BA)
Strada Provinciale per Casamassima km 3, c/o Tecnopolis Parco Scientifico e Tecnologico s.c.a.r.l. Unipersonale – Edificio H 2° piano (moduli 301-308)
Almawave S.p.A.
70010 Valenzano (BA)
Strada Provinciale per Casamassima km 3, c/o Tecnopolis Parco Scientifico e Tecnologico s.c.a.r.l. Unipersonale – Edificio H 2° piano (moduli 312-316)
Operation post code
Almaviva Digitaltec S.r.l.
70010 Valenzano (BA)
Strada Provinciale per Casamassima km 3, c/o Tecnopolis Parco Scientifico e Tecnologico s.c.a.r.l. Unipersonale – Edificio H 2° piano (moduli 301-308)
Almawave S.p.A.
70010 Valenzano (BA)
Strada Provinciale per Casamassima km 3, c/o Tecnopolis Parco Scientifico e Tecnologico s.c.a.r.l. Unipersonale – Edificio H 2° piano (moduli 312-316)
Single project code
Almaviva Digitaltec S.r.l.
B69J23000010007
Almawave S.p.A.
B69J23000020007
Single project code
Almaviva Digitaltec S.r.l.
B69J23000010007
Almawave S.p.A.
B69J23000020007
Country
Italy
Name of operation category
Operation co-financed with the European Regional Development Fund Puglia POR Puglia 2014 - 2020 “The Future Accessible to All”
Asse I – Obiettivo specifico 1a – Azione 1.1 (R&S); Titolo II – capo 1 “Aiuti ai programmi di investimento delle GRANDI IMPRESE” (articolo 17 del Regolamento Regionale n. 17 del 30/09/2014 e s.m.i.)
Name of operation category
Operation co-financed with the European Regional Development Fund Puglia POR Puglia 2014 - 2020 “The Future Accessible to All”
Asse I – Obiettivo specifico 1a – Azione 1.1 (R&S); Titolo II – capo 1 “Aiuti ai programmi di investimento delle GRANDI IMPRESE” (articolo 17 del Regolamento Regionale n. 17 del 30/09/2014 e s.m.i.)
Date of the last update to the list of operations
06/06/2023
Learn more about
- About us
- Our Group
- Corporate governance
- Sustainability
- Media
- News
- Press Release
- Press Contact
- Work with us
- Work with us
- Investor Relations
- Group Profile
- Reports and Presentations
- Communications
- Calendar
- Contact us
Copyright Almaviva S.p.A. 2018
Head office and offices
00137 Rome
Via di Casal Boccone, 188-190
tel. (+39)-06.39931
C.F./P.IVA 08450891000